Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Karyopharm Therapeutics Inc. sell blaugold

Start price
€7.80
01.03.26 / 50%
Target price
-
01.03.27
Performance (%)
-12.18%
End price
€6.85
13.03.26
Summary
This prediction ended on 13.03.26 with a price of €6.85. The prediction for Karyopharm Therapeutics Inc. closed with a convincing performance of -12.18%. blaugold has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Karyopharm Therapeutics Inc. - -
iShares Core DAX® 2,49 % -5,94 %
iShares Nasdaq 100 1,65 % -2,46 %
iShares Nikkei 225® 0,55 % -7,60 %
iShares S&P 500 1,35 % -2,94 %

According to blaugold what are the pros and cons of Karyopharm Therapeutics Inc. for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment

Comments by blaugold for this prediction

In the thread Karyopharm Therapeutics Inc. diskutieren

Sell Karyopharm Therapeutics Inc.

In the thread Trading Karyopharm Therapeutics Inc.
Prediction Sell
Perf. (%) -12.18%
Target price
Change
Ends at 01.03.27

Sell beendet